Immunoglobulin therapy and intestinal blood flows in neonates
Not Applicable
- Conditions
- Health Condition 1: null- neonates who have Rh isoimmunization and alloimmune thrombocytopenia
- Registration Number
- CTRI/2011/08/001955
- Lead Sponsor
- Praveen Kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Neonate receiving intravenous immunoglobulin, irrespective of their gestation and birth weight
Exclusion Criteria
?Neonates with established NEC or surgical abdomen like malrotation prior to starting IVIg
?Neonates developing complications of immunoglobulin therapy like hypotension or anaphylaxis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Superior mesenteric artery and Celiac artery Doppler indices after immunoglobulin therapyTimepoint: Baseline and after giving immunoglobulin therapy
- Secondary Outcome Measures
Name Time Method Incidence of NEC and feed intoleranceTimepoint: with in 5 days of the infusion